DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹2.00 Cr | - | - | - | ₹0.35 Cr |
What is the latest Total Debt ratio of DIVIS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹2.00 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | ₹0.35 Cr |
How is Total Debt of DIVIS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.00 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | -100.00 | |
| Mar2021 | ₹0.35 Cr | - | |
Compare Total Debt of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹171,794.4 Cr | -0.1% | -4.8% | 3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,343.0 Cr | -0.7% | 7.4% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,665.0 Cr | 2.2% | 6.3% | 11.4% | Stock Analytics | |
| CIPLA | ₹122,878.0 Cr | -0.6% | 1.2% | NA | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,581.0 Cr | 1.5% | 6.4% | 4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹91,161.8 Cr | -1.9% | -6.8% | -15.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -0.1% |
-4.8% |
3.3% |
| SENSEX | -0.5% |
1.5% |
6.9% |
You may also like the below Video Courses